![]() |
|
|
Forward to a colleague |
||
Product Brochure ![]() Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here Access Full Stories Vioxx (rofecoxib) might have been offered a lifeline with the news that the drug could be used safely, so long as drugs such as GlaxoSmithKline's investigational dyslipidaemia compound are administered at the same... Read Sangamo points finger at blood vessel growth Sangamo Biosciences is engineering synthetic versions of the body's natural DNA regulators for a variety of therapeutic purposes, including against cancer, HIV/AIDS and diabetic neuropathy... Read Bigger is better, reveals CRO survey In terms of contract research organisations (CROs), bigger is actually better, reveals a recent Lehman Brothers survey, which offers some fresh insight into this growing industry... Read Raising the standard of proteomics data A new series of reporting guidelines have been developed by researchers from the European Molecular Biology Laboratory (EMBL) in an effort to aid proteomics data integration and comparison... Read Drugs moving into the clinic: 26 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read |
||||||||||
All News Headlines for: August | July | June |
||||||||||
![]() A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here |
||||||||||
|
Related Industry News Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving Hutchison MediPharma, Tripos and Clinical Data... Read Encap expands Scottish drug delivery biz Scottish drug delivery firm Encap has announced it has kicked off the construction of a new plant in Scotland to meet growing demand for its contract encapsulation services... Read ALK-Abello and Catalent to increase Grazax production ALK-Abello will be funding a new DKK 300m (€40.3m) production line dedicated to its oral grass pollen allergy vaccine at Catalent Pharma Solutions' UK facility... Read Novartis expands on Rasilez news 24 hours after announcing EU approval of its hypertension drug Rasilez (aliskiren), Novartis has unveiled plans for a major expansion to production facilities in Switzerland... Read
|
||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||